← Open Payments lookup

HUMAYUN KABIR: Open Payments

NPI 1821638438 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,364 in 145 payments from 16 companies in 2025. Trend: 2023 $1,682 · 2024 $1,894 · 2025 $2,364

Food & beverage: $2,364
CompanyPaymentsAmount
ABBVIE INC.34$453
E.R. Squibb & Sons, L.L.C.18$318
Otsuka America Pharmaceutical, Inc.14$245
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$239
Neurocrine BioSciences, Inc.16$224
Alkermes, Inc.10$204
Teva Pharmaceuticals USA, Inc.11$136
Vanda Pharmaceuticals Inc.8$135
Janssen Pharmaceuticals, Inc5$106
Takeda Pharmaceuticals U.S.A., Inc.4$102

Products named: VRAYLAR, COBENFY, CAPLYTA, INGREZZA, REXULTI, ARISTADA, AUSTEDO XR, FANAPT.

Industry payments across VA — which companies pay providers there.